Cargando…
Early intervention in panic: randomized controlled trial and cost-effectiveness analysis
BACKGROUND: Panic disorder (PD) is a common, severe and persistent mental disorder, associated with a high degree of distress and occupational and social disability. A substantial proportion of the population experiences subthreshold and mild PD and is at risk of developing a chronic PD. A promising...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2630960/ https://www.ncbi.nlm.nih.gov/pubmed/19038038 http://dx.doi.org/10.1186/1745-6215-9-67 |
_version_ | 1782163886924890112 |
---|---|
author | Meulenbeek, Peter Willemse, Godelief Smit, Filip van Balkom, Anton Spinhoven, Philip Cuijpers, Pim |
author_facet | Meulenbeek, Peter Willemse, Godelief Smit, Filip van Balkom, Anton Spinhoven, Philip Cuijpers, Pim |
author_sort | Meulenbeek, Peter |
collection | PubMed |
description | BACKGROUND: Panic disorder (PD) is a common, severe and persistent mental disorder, associated with a high degree of distress and occupational and social disability. A substantial proportion of the population experiences subthreshold and mild PD and is at risk of developing a chronic PD. A promising intervention, aimed at preventing panic disorder onset and reducing panic symptoms, is the 'Don't Panic' course. It consists of eight sessions of two hours each. The purpose of this study is to evaluate the effectiveness of this early intervention – based on cognitive behavioural principles – on the reduction of panic disorder symptomatology. We predict that the experimental condition show superior clinical and economic outcomes relative to a waitlisted control group. METHODS/DESIGN: A pragmatic, pre-post, two-group, multi-site, randomized controlled trial of the intervention will be conducted with a naturalistic follow-up at six months in the intervention group. The participants are recruited from the general population and are randomized to the intervention or a waitlist control group. The intervention is offered by community mental health centres. Included are people over 18 years of age with subthreshold or mild panic disorder, defined as having symptoms of PD falling below the cut-off of 13 on the Panic Disorder Severity Scale-Self Report (PDSS-SR). Primary outcomes are panic disorder and panic symptoms. Secondary outcomes are symptoms of agoraphobia, anxiety, cognitive aspects of panic disorder, depressive symptoms, mastery, health-related quality of life, and cost-effectiveness. We will examine the following variables as potential mediators: cognitive aspects of panic disorder, symptoms of agoraphobia, anxiety and mastery. Potential moderating variables are: socio-demographic characteristics, panic disorder, agoraphobia, treatment credibility and mastery. DISCUSSION: This study was designed to evaluate the (cost) effectiveness of an early intervention based on cognitive behavioural principles. The strong external validity is one of the strengths of the study design. TRIAL REGISTRATION: Current Controlled Trials ISRCTN33407455. |
format | Text |
id | pubmed-2630960 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-26309602009-01-27 Early intervention in panic: randomized controlled trial and cost-effectiveness analysis Meulenbeek, Peter Willemse, Godelief Smit, Filip van Balkom, Anton Spinhoven, Philip Cuijpers, Pim Trials Study Protocol BACKGROUND: Panic disorder (PD) is a common, severe and persistent mental disorder, associated with a high degree of distress and occupational and social disability. A substantial proportion of the population experiences subthreshold and mild PD and is at risk of developing a chronic PD. A promising intervention, aimed at preventing panic disorder onset and reducing panic symptoms, is the 'Don't Panic' course. It consists of eight sessions of two hours each. The purpose of this study is to evaluate the effectiveness of this early intervention – based on cognitive behavioural principles – on the reduction of panic disorder symptomatology. We predict that the experimental condition show superior clinical and economic outcomes relative to a waitlisted control group. METHODS/DESIGN: A pragmatic, pre-post, two-group, multi-site, randomized controlled trial of the intervention will be conducted with a naturalistic follow-up at six months in the intervention group. The participants are recruited from the general population and are randomized to the intervention or a waitlist control group. The intervention is offered by community mental health centres. Included are people over 18 years of age with subthreshold or mild panic disorder, defined as having symptoms of PD falling below the cut-off of 13 on the Panic Disorder Severity Scale-Self Report (PDSS-SR). Primary outcomes are panic disorder and panic symptoms. Secondary outcomes are symptoms of agoraphobia, anxiety, cognitive aspects of panic disorder, depressive symptoms, mastery, health-related quality of life, and cost-effectiveness. We will examine the following variables as potential mediators: cognitive aspects of panic disorder, symptoms of agoraphobia, anxiety and mastery. Potential moderating variables are: socio-demographic characteristics, panic disorder, agoraphobia, treatment credibility and mastery. DISCUSSION: This study was designed to evaluate the (cost) effectiveness of an early intervention based on cognitive behavioural principles. The strong external validity is one of the strengths of the study design. TRIAL REGISTRATION: Current Controlled Trials ISRCTN33407455. BioMed Central 2008-11-27 /pmc/articles/PMC2630960/ /pubmed/19038038 http://dx.doi.org/10.1186/1745-6215-9-67 Text en Copyright © 2008 Meulenbeek et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Study Protocol Meulenbeek, Peter Willemse, Godelief Smit, Filip van Balkom, Anton Spinhoven, Philip Cuijpers, Pim Early intervention in panic: randomized controlled trial and cost-effectiveness analysis |
title | Early intervention in panic: randomized controlled trial and cost-effectiveness analysis |
title_full | Early intervention in panic: randomized controlled trial and cost-effectiveness analysis |
title_fullStr | Early intervention in panic: randomized controlled trial and cost-effectiveness analysis |
title_full_unstemmed | Early intervention in panic: randomized controlled trial and cost-effectiveness analysis |
title_short | Early intervention in panic: randomized controlled trial and cost-effectiveness analysis |
title_sort | early intervention in panic: randomized controlled trial and cost-effectiveness analysis |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2630960/ https://www.ncbi.nlm.nih.gov/pubmed/19038038 http://dx.doi.org/10.1186/1745-6215-9-67 |
work_keys_str_mv | AT meulenbeekpeter earlyinterventioninpanicrandomizedcontrolledtrialandcosteffectivenessanalysis AT willemsegodelief earlyinterventioninpanicrandomizedcontrolledtrialandcosteffectivenessanalysis AT smitfilip earlyinterventioninpanicrandomizedcontrolledtrialandcosteffectivenessanalysis AT vanbalkomanton earlyinterventioninpanicrandomizedcontrolledtrialandcosteffectivenessanalysis AT spinhovenphilip earlyinterventioninpanicrandomizedcontrolledtrialandcosteffectivenessanalysis AT cuijperspim earlyinterventioninpanicrandomizedcontrolledtrialandcosteffectivenessanalysis |